Literature DB >> 28164251

State-dependent block of voltage-gated sodium channels by the casein-kinase 1 inhibitor IC261.

Karl J Föhr1, Uwe Knippschild2, Anna Herkommer3, Michael Fauler4, Christian Peifer5, Michael Georgieff6, Oliver Adolph6.   

Abstract

Background and Purpose IC261 (3-[(2,4,6-trimethoxyphenyl)methylidenyl]-indolin-2-one) has previously been introduced as an isoform specific inhibitor of casein kinase 1 (CK1) causing cell cycle arrest or cell death of established tumor cell lines. However, it is reasonable to assume that not all antitumor activities of IC261 are mediated by the inhibition of CK1. Meanwhile there is growing evidence that functional voltage-gated sodium channels are also implicated in the progression of tumors as their blockage suppresses tumor migration and invasion of different tumor cell lines. Thus, we asked whether IC261 functionally inhibits voltage-gated sodium channels. Experimental Approach Electrophysiological experiments were performed using the patch-clamp technique at human heart muscle sodium channels heterologously expressed in human TsA cells. Key Results IC261 inhibits sodium channels in a state-dependent manner. IC261 does not interact with the open channel and has only a low affinity for the resting state of the hNav1.5 (human voltage-gated sodium channel; Kr: 120 μM). The efficacy of IC261 strongly increases with membrane depolarisation, indicating that the inactivated state is an important target. The results of different experimental approaches finally revealed an affinity of IC261 to the inactivated state between 1 and 2 μM. Conclusion and Implications IC261 inhibits sodium channels at a similar concentration necessary to reduce CK1δ/ε activity by 50% (IC50 value 1 μM). Thus, inhibition of sodium channels might contribute to the antitumor activity of IC261.

Entities:  

Keywords:  Cytotoxicity; IC261; Patch clamp; Sodium channel; Tumor growth

Mesh:

Substances:

Year:  2017        PMID: 28164251     DOI: 10.1007/s10637-017-0429-0

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  52 in total

1.  Lidocaine partially depolarizes the S4 segment in domain IV of the sodium channel.

Authors:  Michael F Sheets; Tiehua Chen; Dorothy A Hanck
Journal:  Pflugers Arch       Date:  2010-10-28       Impact factor: 3.657

2.  Na channel inactivation from open and closed states.

Authors:  Clay M Armstrong
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-13       Impact factor: 11.205

3.  Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis.

Authors:  Scott P Fraser; James K J Diss; Athina-Myrto Chioni; Maria E Mycielska; Huiyan Pan; Rezan F Yamaci; Filippo Pani; Zuzanna Siwy; Monika Krasowska; Zbigniew Grzywna; William J Brackenbury; Dimis Theodorou; Meral Koyutürk; Handan Kaya; Esra Battaloglu; Manuela Tamburo De Bella; Martin J Slade; Robert Tolhurst; Carlo Palmieri; Jie Jiang; David S Latchman; R Charles Coombes; Mustafa B A Djamgoz
Journal:  Clin Cancer Res       Date:  2005-08-01       Impact factor: 12.531

4.  Alternative splicing of Nav1.5: an electrophysiological comparison of 'neonatal' and 'adult' isoforms and critical involvement of a lysine residue.

Authors:  Rustem Onkal; Joanna H Mattis; Scott P Fraser; James K J Diss; Dongmin Shao; Kenji Okuse; Mustafa B A Djamgoz
Journal:  J Cell Physiol       Date:  2008-09       Impact factor: 6.384

5.  Ion channels as targets for cancer therapy.

Authors:  Minghua Li; Zhi-Gang Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-06-27

Review 6.  Electrophysiology and beyond: multiple roles of Na+ channel β subunits in development and disease.

Authors:  Gustavo A Patino; Lori L Isom
Journal:  Neurosci Lett       Date:  2010-06-23       Impact factor: 3.046

7.  Anti-apoptotic and growth-stimulatory functions of CK1 delta and epsilon in ductal adenocarcinoma of the pancreas are inhibited by IC261 in vitro and in vivo.

Authors:  C Brockschmidt; H Hirner; N Huber; T Eismann; A Hillenbrand; G Giamas; B Radunsky; O Ammerpohl; B Bohm; D Henne-Bruns; H Kalthoff; F Leithäuser; A Trauzold; U Knippschild
Journal:  Gut       Date:  2008-01-18       Impact factor: 23.059

8.  The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels.

Authors:  Adam C Errington; Thomas Stöhr; Cara Heers; George Lees
Journal:  Mol Pharmacol       Date:  2007-10-16       Impact factor: 4.436

9.  Therapeutic potential for phenytoin: targeting Na(v)1.5 sodium channels to reduce migration and invasion in metastatic breast cancer.

Authors:  Ming Yang; David J Kozminski; Lindsey A Wold; Rohan Modak; Jeffrey D Calhoun; Lori L Isom; William J Brackenbury
Journal:  Breast Cancer Res Treat       Date:  2012-06-08       Impact factor: 4.872

10.  Alleviation of behavioral hypersensitivity in mouse models of inflammatory pain with two structurally different casein kinase 1 (CK1) inhibitors.

Authors:  Takashi Kurihara; Eri Sakurai; Masayasu Toyomoto; Isao Kii; Daisuke Kawamoto; Toshihide Asada; Tsutomu Tanabe; Megumu Yoshimura; Masatoshi Hagiwara; Atsuro Miyata
Journal:  Mol Pain       Date:  2014-03-10       Impact factor: 3.395

View more
  5 in total

Review 1.  Targeting Ion Channels for Cancer Treatment: Current Progress and Future Challenges.

Authors:  Alina L Capatina; Dimitris Lagos; William J Brackenbury
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

Review 2.  Structure, regulation, and (patho-)physiological functions of the stress-induced protein kinase CK1 delta (CSNK1D).

Authors:  Pengfei Xu; Chiara Ianes; Fabian Gärtner; Congxing Liu; Timo Burster; Vasiliy Bakulev; Najma Rachidi; Uwe Knippschild; Joachim Bischof
Journal:  Gene       Date:  2019-07-31       Impact factor: 3.688

3.  Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK.

Authors:  Jakob Halekotte; Lydia Witt; Chiara Ianes; Marc Krüger; Mike Bührmann; Daniel Rauh; Christian Pichlo; Elena Brunstein; Andreas Luxenburger; Ulrich Baumann; Uwe Knippschild; Joachim Bischof; Christian Peifer
Journal:  Molecules       Date:  2017-03-24       Impact factor: 4.411

4.  IC261, a specific inhibitor of CK1δ/ε, promotes aerobic glycolysis through p53-dependent mechanisms in colon cancer.

Authors:  Min Liu; Yuhan Hu; Shuya Lu; Manman Lu; Jingsong Li; Haimin Chang; Huijie Jia; Min Zhou; Feng Ren; Jiateng Zhong
Journal:  Int J Biol Sci       Date:  2020-01-17       Impact factor: 6.580

5.  Newly Developed CK1-Specific Inhibitors Show Specifically Stronger Effects on CK1 Mutants and Colon Cancer Cell Lines.

Authors:  Congxing Liu; Lydia Witt; Chiara Ianes; Joachim Bischof; Marie-Thérèse Bammert; Joana Baier; Stefan Kirschner; Doris Henne-Bruns; Pengfei Xu; Marko Kornmann; Christian Peifer; Uwe Knippschild
Journal:  Int J Mol Sci       Date:  2019-12-07       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.